HOOFDDORP, THE NETHERLANDS--(Marketwire - November 19, 2007) - PolyPeptide Laboratories Group, a leading global provider of custom and generic GMP-grade peptides for a range of pharmaceutical and biotechnology applications, today announced its acquisition of peptide manufacturing group NeoMPS from Isochem, the fine chemicals subsidiary of the French Groupe SNPE. NeoMPS operates facilities in France (Strasbourg) and the United States (San Diego).
